失调
肺炎克雷伯菌
肠道菌群
生物
肝损伤
微生物学
甲硝唑
炎症
免疫学
拟杆菌
殖民抵抗
微生物群
肝移植
肝性脑病
肠粘膜
胃肠道
败血症
转录组
原发性硬化性胆管炎
势垒函数
胆汁酸
脆弱类杆菌
肝功能
医学
医学微生物学
急性期蛋白
免疫
作者
Xiaoyi Wang,Hui Yang,Hongyu Chu,Xue Zhang,Jiwen Li,Man Liu,Simin Zhou,Zhen Yang,Jingwen Zhao,Bangmao Wang,Ying Ran,Long Li,Lu Zhou
标识
DOI:10.1186/s13099-026-00880-y
摘要
Although gut dysbiosis is recognized as a key environmental factor, the mechanisms by which specific members of the microbiota drive primary biliary cholangitis (PBC) progression by impacting hepatic immunity and metabolism remains incompletely understood. We established a PBC-fecal microbiota transplantation (FMT) mouse model by fecal transplantation. Liver injury and gut barrier integrity were assessed using serological, histological, and molecular metrics. The microbiota was analyzed by 16 S rDNA sequencing, and K. pneumoniae was tracked by culture, fluorescence in situ hybridization (FISH), and PCR. Spearman correlation analysis was used to evaluate microbiota-clinical correlations and profile the hepatic transcriptome via RNA-seq. K. pneumoniae pathogenicity was tested by mono-colonization, and the effect of metronidazole was evaluated in the PBC-FMT model. PBC-FMT successfully induced cholestatic liver injury, anti-mitochondrial antibody production, and pericholangitis in mice. Model mice exhibited altered gut microbiota composition, characterized by reduced beneficial bacteria, enrichment of potentially pathogenic bacteria (e.g., Bacteroides and Aeromonas ), and intestinal barrier damage. Liver RNA-seq revealed a significant activation of immune-inflammatory pathways and suppression of various metabolic pathways in the PBC-FMT group. K. pneumoniae colonization was detected in the livers of both model mice and patients with PBC, and its abundance was positively correlated with liver function indices. Mono-colonization experiments confirmed that K. pneumoniae can disrupt the intestinal barrier, translocate to the liver, and induce liver injury and metabolic pathway disturbances. Metronidazole (MNZ) intervention partially alleviated liver injury in PBC-FMT mice and reversed some transcriptional pathways related to K. pneumoniae . Gut microbiota from patients with PBC can drive PBC-like liver injury, with gut-liver translocation of K. pneumoniae constituting an important event. This bacterium likely contributes to disease progression by impairing metabolic functions such as bile acid metabolism.
科研通智能强力驱动
Strongly Powered by AbleSci AI